Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 400

The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.

Cancer in sub-Saharan Africa: a Lancet Oncology Commission

Open access
Ngwa, Wilfred, Addai, Beatrice W, Adewole, Isaac, Ainsworth, Victoria, Alaro, James, Alatise, Olusegun I, Ali, Zipporah, Anderson, Benjamin O, Anorlu, Rose, Avery, Stephen, Barango, Prebo, Bih, Noella, Booth, Christopher M, Brawley, Otis W, Dangou, Jean-Marie, Denny, Lynette, Dent, Jennifer, Elmore, Shekinah N C, Elzawawy, Ahmed, Gashumba, Diane, Geel, Jennifer, Graef, Katy, Gupta, Sumit, Gueye, Serigne-Magueye, Hammad, Nazik, Hessissen, Laila, Ilbawi, Andre M, Kambugu, Joyce, Kozlakidis, Zisis, Manga, Simon, Maree, Lize, Mohammed, Sulma I, Msadabwe, Susan, Mutebi, Miriam, Nakaganda, Annet, Ndlovu, Ntokozo, Ndoh, Kingsley, Ndumbalo, Jerry, Ngoma, Mamsau, Ngoma, Twalib, Ntizimira, Christian, Rebbeck, Timothy R, Renner, Lorna, Romanoff, Anya, Rubagumya, Fidel, Sayed, Shahin, Sud, Shivani, Simonds, Hannah, Sullivan, Richard, Swanson, William, Vanderpuye, Verna, Wiafe, Boateng, Kerr, David·2022·The Lancet Oncology

Abstract

In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer incidence and mortality. Without rapid interventions, data estimates show a major increase in cancer mortality from 520 348 in 2020 to about 1 million deaths per year by 2030. Here, we detail the state of cancer in SSA, recommend key actions on the basis of analysis, and highlight case studies and successful models that can be emulated, adapted, or improved across the region to reduce the growing cancer crises. Recommended actions begin with the need to develop or update national cancer control plans in each country. Plans must include childhood cancer plans, managing comorbidities such as HIV and malnutrition, a reliable and predictable supply of medication, and the provision of psychosocial, supportive, and palliative care. Plans should also engage traditional, complementary, and alternative medical practices employed by more than 80% of SSA populations and pathways to reduce missed diagnoses and late referrals. More substantial investment is needed in developing cancer registries and cancer diagnostics for core cancer tests. We show that investments in, and increased adoption of, some approaches used during the COVID-19 pandemic, such as hypofractionated radiotherapy and telehealth, can substantially increase access to cancer care in Africa, accelerate cancer prevention and control efforts, increase survival, and save billions of US dollars over the next decade. The involvement of African First Ladies in cancer prevention efforts represents one practical approach that should be amplified across SSA. Moreover, investments in workforce training are crucial to prevent millions of avoidable deaths by 2030. We present a framework that can be used to strategically plan cancer research enhancement in SSA, with investments in research that can produce a return on investment and help drive policy and effective collaborations. Expansion of universal health coverage to incorporate cancer into essential benefits packages is also vital. Implementation of the recommended actions in this Commission will be crucial for reducing the growing cancer crises in SSA and achieving political commitments to the UN Sustainable Development Goals to reduce premature mortality from non-communicable diseases by a third by 2030.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(21)00720-8

Cites

206 of 206 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 206 references

Cited by

See all 400

Metadata

Authors
Ngwa, W., Addai, B. W., Adewole, I., Ainsworth, V., Alaro, J., Alatise, O. I., Ali, Z., Anderson, B. O., Anorlu, R., Avery, S., Barango, P., Bih, N., Booth, C. M., Brawley, O. W., Dangou, J.-M., Denny, L., Dent, J., Elmore, S. N. C., Elzawawy, A., Gashumba, D., Geel, J., Graef, K., Gupta, S., Gueye, S.-M., Hammad, N., Hessissen, L., Ilbawi, A. M., Kambugu, J., Kozlakidis, Z., Manga, S., Maree, L., Mohammed, S. I., Msadabwe, S., Mutebi, M., Nakaganda, A., Ndlovu, N., Ndoh, K., Ndumbalo, J., Ngoma, M., Ngoma, T., Ntizimira, C., Rebbeck, T. R., Renner, L., Romanoff, A., Rubagumya, F., Sayed, S., Sud, S., Simonds, H., Sullivan, R., Swanson, W., Vanderpuye, V., Wiafe, B., & Kerr, D.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2022-06
Volume
23
Issue
6
Pages
e251-e312
ISSN
1470-2045 (ISSN-L)
OpenAlex
W4229439346
Cited by
400
References
206
FWCI
37.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cancer in sub-Saharan Africa: a Lancet Oncology Commission. https://app.cochat.ai/papers/10.1016/s1470-2045(21)00720-8
The paper
Ngwa, W., Addai, B. W., Adewole, I., Ainsworth, V., Alaro, J., Alatise, O. I., Ali, Z., Anderson, B. O., Anorlu, R., Avery, S., Barango, P., Bih, N., Booth, C. M., Brawley, O. W., Dangou, J.-M., Denny, L., Dent, J., Elmore, S. N. C., Elzawawy, A., . . . Kerr, D. (2022). Cancer in sub-Saharan Africa: a Lancet Oncology Commission. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(21)00720-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.